Consequently, high levels of Th1, Th17, and inflammatory CD14+CD16+ monocytes release more cytokines that activate macrophages and fibroblasts resulting in overwhelming amounts of proinflammatory cytokines [21,22] associated with severe lung pathology in COVID-19 patients [3]. The gene discussed is CD14; the disease is COVID-19.